Literature DB >> 17483616

[The natural history of acetabular development in developmental dysplasia of the hip].

Paul Connolly1, Stuart L Weinstein.   

Abstract

Normal hip joint development requires a genetically determined balance of growth between the acetabular and triradiate cartilage, and a well-centered femoral head. It is unclear how and why this delicate balance becomes disrupted, leading to abnormal development of the hip joint. It is known that, without treatment, a certain number of hips will become problematic later in life. This article outlines normal hip joint development and discusses the natural history of acetabular development in developmental dysplasia of the hip (DDH). The natural history of DDH depends on many factors including age of diagnosis, the growth capacity of the involved structures, and the effects of treatment interventions. Early identification and treatment of hip instability maximizes the chance for normal hip development to occur. However, close observation of the child is crucial to identify individuals where normal development is not occurring. Intervention may become necessary in certain situations to positively affect hip joint development.

Entities:  

Mesh:

Year:  2007        PMID: 17483616

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  2 in total

1.  Investigation of sensory nerve endings in pulvinar, ligamentum teres, and hip joint capsule: A prospective immunohistochemical study of 36 cases with developmental hip dysplasia.

Authors:  Cemil Ertürk; Sezen Koçarslan; Halil Büyükdoğan; Mehmet Akif Altay
Journal:  Acta Orthop Traumatol Turc       Date:  2021-01       Impact factor: 1.511

2.  Hip joint pain in children with cerebral palsy and developmental dysplasia of the hip: why are the differences so huge?

Authors:  Andrzej Grzegorzewski; Marek Jóźwiak; Maciej Pawlak; Tadeusz Modrzewski; Piotr Buchcic; Adrian Masłoń
Journal:  BMC Musculoskelet Disord       Date:  2014-03-21       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.